Contraline Stock
Contraline is developing the first long-lasting, reversible contraceptive for men
Sign up today and learn more about Contraline Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Contraline Stock
Contraline is a biotechnology company developing a long-lasting, non-hormonal, and reversible male contraceptive.
Funding History
July 2014 | $0 |
---|---|
June 2016 | $680K |
March 2017 | $2.3M |
July 2018 | $0 |
September 2018 | $0 |
Management
COO
Nicole E. Hastings
Co-Founder & CEO
Kevin Eisenfrats
Press
patents - Apr, 14 2024
Systems and methods for delivering biomaterialspatents - Apr, 14 2024
Compositions and methods for sustained drug release from an injectable hydrogelpatents - Apr, 14 2024
Systems and methods for automated image recognition of implants and …patents - Apr, 14 2024
Systems and methods for delivering a compositionpatents - Apr, 14 2024
Methods For Implanting And Reversing Stimuli-Responsive Implants